Korea's Samsung Biologics signs $668 M worth manufacturing deal with European pharma company

Samsung Biologics, a global contract development and manufacturing organisation (CDMO) based in South Korea, has announc...

November 21, 2024 | Thursday | News
Chime Biologics and Waterstone team up to empower ADC development and manufacturing

China-based Chime Biologics, a leading global contract development and manufacturing organisation (CDMO) that enables it...

November 13, 2024 | Wednesday | News
Lonza expands Bioconjugation capabilities with two additional manufacturing suites in Switzerland

Lonza, a global development and manufacturing partner to the pharmaceutical, biotech and nutraceutical markets, has anno...

November 12, 2024 | Tuesday | News
GenScript Biotech sets up new operations and logistics hub in Australia

GenScript Biotech Corporation, a global leader in life sciences services and products, has announced the establishment o...

November 12, 2024 | Tuesday | News
Avance Clinical’s CEO Yvonne Lungershausen on Expanding Footprint in Asia-Pacific: A Strategic Focus on South Korea’s Clinical Excellence

In a recent conversation with Ankit Kankar from BioSpectrum Asia, Yvonne Lungershausen, CEO of Avance Clinical, shared i...

November 11, 2024 | Monday | News
Fujifilm launches first phase of global CDMO ecosystem expansion

Fujifilm Diosynth Biotechnologies, a world-leading contract development and manufacturing organisation (CDMO) for biolog...

November 8, 2024 | Friday | News
Merck invests $76 M to expand ADC manufacturing for novel cancer therapies

MilliporeSigma, the US and Canada Life Science business of Merck KGaA, Darmstadt, Germany, has announced a $76 million e...

October 30, 2024 | Wednesday | News
China's WuXi Biologics launches WuXia RidGS for non-antibiotic cell line development

China-based WuXi Biologics, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), has...

October 29, 2024 | Tuesday | News
Samsung Biologics inks largest ever manufacturing deal of $1.24 B with Asia-based pharma

South Korea-based Samsung Biologics, a global contract development and manufacturing organization (CDMO), has annou...

October 22, 2024 | Tuesday | News
EirGenix's comprehensive CDMO services strengthening Taiwan’s position in the global biopharmaceutical landscape

EirGenix (HQ: Taipei, Taiwan), an established Taiwanese Contract Development and Manufacturing Organization (CDMO), spec...

October 4, 2024 | Friday | Opinion
Bora Appoints J.D. Mowery as First Division President of its CDMO biz

Taiwan-based Bora Pharmaceuticals Co. has announced the appointment of J.D. Mowery to the newly created position of Divi...

October 3, 2024 | Thursday | News
SK pharmteco invests $260 M in Korea facility to expand global small molecule and peptide production

US-headquartered SK pharmteco, a global contract development and manufacturing organisation (CDMO), has announced a majo...

October 1, 2024 | Tuesday | News
Cytiva opens its first Innovation Hub in South Korea

Cytiva, a global life sciences leader, has opened its first Innovation Hub in Korea, located in the Songdo Bio-cluster i...

September 30, 2024 | Monday | News
Thermo Fisher Scientific expands oral solid dose development and manufacturing capabilities across North America

To provide flexible and innovative solutions for early development challenges commonly faced by biotech and pharmaceutic...

September 26, 2024 | Thursday | News
Korea's Samsung Biologics launches development platforms for enhanced therapeutic efficacy

South Korea-based Samsung Biologics, a global contract development and manufacturing organisation (CDMO), has launched a...

September 26, 2024 | Thursday | News
Taiwan's Bora Pharmaceuticals makes strategic investment into Tanvex for global biomanufacturing services

Taiwan-based Bora Pharmaceuticals Co. has announced that its Board of Directors has approved a strategic investment into...

August 28, 2024 | Wednesday | News
Korean CDMO ST Pharm accelerates manufacturing of RNA-based vaccines therapeutics with Quantoom Biosciences

ST Pharm, a leading technology-driven RNA CDMO based in South Korea, and Belgium-based Quantoom Biosciences, a specialis...

August 20, 2024 | Tuesday | News
Andelyn Biosciences Expands AAV Curator™ Platform with Broad Institute's MyoAAV Plasmids

Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Or...

August 7, 2024 | Wednesday | News